Volume 75, Number 17, October 26, 2010
About this course
- Released: 10/25/2010
- Expires: 10/26/2012
Learning Objectives:
Upon completion of the article by Brouwer et al, the participant should be able to:
• Briefly summarize the findings of previous studies assessing the effectiveness of adjunctive dexamethasone in bacterial meningitis.
• State the standard dosage of adjunctive dexamethasone therapy used in this national cohort.
• Discuss the evidence in this study for the effectiveness of intravenous dexamethasone in reducing the proportion of patients with unfavorable outcome and reduced mortality in adults with pneumococcal meningitis.
Core Competencies:
The article by Brouwer et al, covers the following core competency:
• Medical Knowledge
• Systems-based practice
Learning Objectives:
Upon completion of the article by de Greef et al, the participant should be able to:
• Briefly describe the clinical features of facioscapulohumeral muscular dystrophy (FSHD).
• Define FSHD1 and FSHD2.
• Recognize that patients with FSHD2 are indistinguishable from patients with FSHD1 and may be the result of the same pathophysiologic process.
Core Competencies:
The article by de Greef et al, covers the following core competency:
• Medical Knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
